JESÚS FERNANDO
SAN MIGUEL IZQUIERDO
Investigador en el periodo 1986-2013
Publicaciones en las que colabora con JESÚS FERNANDO SAN MIGUEL IZQUIERDO (45)
2022
2016
-
Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse
Oncotarget, Vol. 7, Núm. 49, pp. 80664-80679
-
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
Leukemia Research, Vol. 40, pp. 1-9
-
Post-transcriptional modifications contribute to the upregulation of cyclin D2 in multiple myeloma
Clinical Cancer Research, Vol. 22, Núm. 1, pp. 207-217
2014
-
Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies
Haematologica, Vol. 99, Núm. 8, pp. 1365-1372
2012
-
SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status
Leukemia, Vol. 26, Núm. 12, pp. 2521-2529
2010
-
Immunomodulatory effect of 5-azacytidine (5-azaC): Potential role in the transplantation setting
Blood, Vol. 115, Núm. 1, pp. 107-121
-
P53 deletion may drive the clinical evolution and treatment response in multiple myeloma
European Journal of Haematology, Vol. 84, Núm. 4, pp. 359-361
2009
-
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome
Leukemia, Vol. 23, Núm. 4, pp. 664-672
-
Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
Leukemia, Vol. 23, Núm. 8, pp. 1515-1527
2007
-
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis
British Journal of Haematology, Vol. 136, Núm. 1, pp. 80-86
-
Optimización del uso de Agentes estimulantes del Receptor de la Eritropoyetina (AREs) en pacientes con neoplasias hematológicas basado en el nivel de hemoglobina reticulocitaria
Mapfre Medicina, Vol. 18, Núm. 4, pp. 284-291
2006
-
Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain
Leukemia Research, Vol. 30, Núm. 8, pp. 943-948
2005
-
Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia
Leukemia, Vol. 19, Núm. 3, pp. 402-409
-
Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11
Cancer Genetics and Cytogenetics, Vol. 160, Núm. 1, pp. 68-72
-
Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes [7]
Leukemia
2004
-
Analysis of hematopoietic progenitor cells in patients with myelodysplastic syndromes according to their cytogenetic abnormalities
Leukemia Research, Vol. 28, Núm. 11, pp. 1181-1187
-
Heterogeneity of structural abnormalities in the 7q31.3∼q34 region in myeloid malignancies
Cancer Genetics and Cytogenetics
-
Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma
Blood, Vol. 104, Núm. 9, pp. 2661-2666
-
The value of flourescence in situ hybridization for the detection of 11q in multiple myeloma
Haematologica, Vol. 89, Núm. 10, pp. 1213-1218